DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global In Vitro Diagnostics market accounted for $87.9 billion in 2018 and is expected to reach $164.4 billion by 2027, growing at a CAGR of 7.2% during the forecast period.

Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.

Based on end-user, the point-of-care testing segment is likely to have a huge demand due rising requirements of these testing's as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.

Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomerieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.

What the report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Technology Analysis

3.8 Application Analysis

3.9 End-user Analysis

3.10 Emerging Markets

3.11 Impact of COVID-19

4 Porters Five Force Analysis

5 Global In Vitro Diagnostics Market, By Usability

5.1 Introduction

5.2 Reusable IVD Devices

5.3 Disposable IVD Devices

6 Global In Vitro Diagnostics Market, By Product

6.1 Introduction

6.2 Data Management Software

6.3 Reagents & Kits

6.4 Services

6.5 Instruments

6.5.1 Semi-Automated Instruments

6.5.2 Fully Automated Instruments

7 Global In Vitro Diagnostics Market, By Technology

7.1 Introduction

7.2 Blood Testing

7.3 Coagulation & Hemostasis

7.4 Hematology

7.5 Immunohematology

7.6 Microbiology

7.7 Tissue Diagnostics

7.8 Urinalysis

7.9 Clinical Chemistry

7.9.1 Basic Metabolic Panel

7.9.2 Electrolyte Panel

7.9.3 Lipid Profile

7.9.4 Liver Panel

7.9.5 Renal Profile

7.9.6 Specialty Chemical Tests

7.9.7 Thyroid Function Panel

7.10 Molecular Diagnostics

7.10.1 DNA Sequencing & Next-Generation Sequencing

7.10.2 Isothermal Nucleic Acid Amplification Technology (INAAT)

7.10.3 Microarray

7.10.4 Polymerase Chain Reaction (PCR)

7.10.5 Hybridization

7.10.5.1 In-Situ Hybridization

7.10.5.2 Fluorescence In-Situ Hybridization

7.11 Immunoassay/Immunochemistry

7.11.1 Enzyme-Linked Immunospot Assays

7.11.2 Radioimmunoassay

7.11.3 Rapid Test

7.11.4 Western Blotting

7.11.5 Enzyme-Linked Immunosorbent Assay

7.11.5.1 Chemiluminescence Immunoassays

7.11.5.2 Colorimetric Immunoassays

7.11.5.3 Fluorescence Immunoassays

8 Global In Vitro Diagnostics Market, By Application

8.1 Introduction

8.2 Autoimmune Diseases

8.3 Cardiology

8.4 Diabetes

8.5 Drug Testing/Pharmacogenomics

8.6 Endocrinology

8.7 Gastrointestinal Diseases

8.8 HIV/Aids

8.9 Infectious Diseases

8.10 Nephrology

8.11 Non-Infectious Diseases

8.12 Oncology

9 Global In Vitro Diagnostics Market, By End-user

9.1 Introduction

9.2 Academic Institutes

9.3 Home Care

9.4 Hospitals

9.5 Patient Self-Testing

9.6 Point-of-Care Testing

9.7 Laboratories

9.7.1 Large/Reference Laboratories

9.7.2 Medium-Sized Laboratories

9.7.3 Small Laboratories

10 Global In Vitro Diagnostics Market, By Geography

10.1 Introduction

10.2 North America

10.2.1 US

10.2.2 Canada

10.2.3 Mexico

10.3 Europe

10.3.1 Germany

10.3.2 UK

10.3.3 Italy

10.3.4 France

10.3.5 Spain

10.3.6 Rest of Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 New Zealand

10.4.6 South Korea

10.4.7 Rest of Asia-Pacific

10.5 South America

10.5.1 Argentina

10.5.2 Brazil

10.5.3 Chile

10.5.4 Rest of South America

10.6 Middle East & Africa

10.6.1 Saudi Arabia

10.6.2 UAE

10.6.3 Qatar

10.6.4 South Africa

10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures

11.2 Acquisitions & Mergers

11.3 New Product Launch

11.4 Expansions

11.5 Other Key Strategies

12 Company Profiling

12.1 Abbott Laboratories Inc.

12.2 Agilent Technologies

12.3 Becton Dickinson and Company

12.4 bioMerieux S.A.

12.5 Bio-Rad Laboratories Inc.

12.6 Cepheid

12.7 Danaher Corporation

12.8 Diasorin

12.9 Johnson & Johnson

12.10 Leica Biosystems Nussloch GmbH

12.11 Qiagen

12.12 Roche Diagnostics

12.13 Siemens AG

12.14 Sysmex Corporation

12.15 Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/jb1e17

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Copyright © acrofan/Business Wire All Right Reserved